NetworkNewsBreaks – Lexaria Bioscience Corp.’s
Post# of 721
(Total Views: 200)
Posted On: 05/28/2019 4:40:00 PM
NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH(TM) Combined with Nanotech Delivers 1,137 Percent More CBD into Animal Brain Tissue
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) this morning announced that combining Lexaria’s DehydraTECH(TM) delivery technology with generic nanotech techniques has been proven to deliver 1,137% more cannabidiol (“CBD”) into animal brain tissue following oral ingestion than certain existing industry formulations. According to the update, the results were confirmed in recent testing based on Lexaria’s series of animal studies it announced that it was beginning on March 20, 2019. Results from the studies with multiple objectives, including developing a better understanding of how effectively edible forms of cannabinoids cross the blood-brain-barrier to enter brain tissue, continue to generate additional data.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) this morning announced that combining Lexaria’s DehydraTECH(TM) delivery technology with generic nanotech techniques has been proven to deliver 1,137% more cannabidiol (“CBD”) into animal brain tissue following oral ingestion than certain existing industry formulations. According to the update, the results were confirmed in recent testing based on Lexaria’s series of animal studies it announced that it was beginning on March 20, 2019. Results from the studies with multiple objectives, including developing a better understanding of how effectively edible forms of cannabinoids cross the blood-brain-barrier to enter brain tissue, continue to generate additional data.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Lexaria Bioscience Corp. (LXRPD) Stock Research Links
Scroll down for more posts ▼